Expanding Possibilities in MDD: Exploring Rapid-Acting Therapeutic Options
Gus Alva, MD, DFAPA; Carmen Kosicek, MSN, PMHNP-BC; and Roger McIntyre, MD, FRCPC, explore the evolving treatment landscape of major depressive disorder. They highlight key data and efficacy profiles of various therapeutic approaches focusing on rapid acting therapies, examining real patient cases to ground the conversation in practical application.
Gus Alva, MD, DFAPA, introduces his esteemed colleagues and leads a comprehensive discussion on the complexities of managing major depressive disorder. The conversation addresses the rising prevalence of MDD, the enduring stigma surrounding the condition, and its profound impact on patient quality of life.
Watch
EP. 2: Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics
Published: September 25th 2024 | Updated: September 25th 2024Experts in the management of mood disorders comment on the evolving management of major depressive disorder, emphasizing findings from the STAR*D trial, updated treatment guidelines, and the role of precision medicine and the shift toward personalized, rapid-acting treatments to improve patient outcomes.
Watch
